Search results
Roche's experimental obesity drug shows promising early stage results
United Press International via Yahoo News· 5 days agoSwiss drug company Roche on Thursday said its experimental obesity treatment helped people lose a...
Roche keeps pace in obesity drug field with early study data
BioPharma Dive via Yahoo Finance· 6 days agoA drug Roche acquired in a buyout of Carmot Therapeutics and that works similarly to Zepbound helped...
Gaps remain between what's known about obesity and how it's being treated
San Francisco Chronicle· 1 day agoThe scientific statement from the American Heart Association, published Monday in the journal Circulation, highlights gaps between the growing understanding of the causes and
Is Eli Lilly Stock A Buy Or A Sell With Key Alzheimer's Meeting Looming?
Investor's Business Daily· 6 days agoEli Lilly stock yo-yoed recently after announcing the Food and Drug Administration has scheduled an...
Hims & Hers Stock Spikes. It’s Taking on Big Pharma With Cheap Obesity Shots.
Barrons.com· 1 day agoA relatively small telehealth company that recently went public wants to take a slice of the big...
Wegovy patients maintained weight loss for 4 years, analysis shows
Medical News Today· 1 day agoA new study finds the benefits of Wegovy for diabetes, heart disease, and weight loss can last up to...
Eli Lilly's diabetes drug tirzepatide gets approval in China
Reuters via Yahoo Finance· 19 hours agodrug tirzepatide has received approval from Chinese regulators, setting up intensifying competition...
Gaps remain between what's known about obesity and how it's being treated
Stamford Advocate· 1 day agoThe scientific statement from the American Heart Association, published Monday in the journal Circulation, highlights gaps between the growing understanding of the causes and
A New Index Play on the Diet Drug Revolution | ETF Trends
ETF Trends· 9 hours agoAlthough many survey participants rely on these medications for other conditions like Type 2...
Medicare Coverage of Wegovy Raises Questions Regarding the Affordability and Accessibility of Novel...
The National Law Review· 6 days agoIn Wegovy’s case, the FDA...cardiovascular death, non-fatal myocardial infarction, or non-fatal...